Lunai Bioworks Net Income 2013-2025 | LNAI
Lunai Bioworks net income from 2013 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Lunai Bioworks Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $-178 |
| 2024 | $-88 |
| 2023 | $-40 |
| 2022 | $-113 |
| 2021 | $-27 |
| 2020 | $-11 |
| 2019 | $-18 |
| 2018 | $-6 |
| 2017 | $-2 |
| 2016 | $-2 |
| 2015 | |
| 2014 | $-2 |
| 2014 | $-2 |
| 2013 | $-2 |
| 2013 | $-2 |
|
Lunai Bioworks Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-127 |
| 2025-03-31 | $0 |
| 2024-12-31 | $-7 |
| 2024-09-30 | $-44 |
| 2024-06-30 | $-16 |
| 2024-03-31 | $-59 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-90 |
| 2022-03-31 | $-6 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $1 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-16 |
| 2018-09-30 | $0 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-03-31 | $-1 |
| 2014-12-31 | |
| 2014-09-30 | $-1 |
| 2014-06-30 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.024B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |